>

ASTRAZENECA PHARMA (India) Performance

AS
The firm shows Beta (market volatility) of 0.0 which signifies that the returns on MARKET and ASTRAZENECA PHARMA are completely uncorrelated. Although it is extremely important to respect ASTRAZENECA PHARMA historical returns, it is better to be realistic regarding the information on equity current trending patterns. The philosophy in foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing ASTRAZENECA PHARMA technical indicators you can now evaluate if the expected return of 0.0% will be sustainable into the future. ASTRAZENECA PHARMA currently shows a risk of 0.0%. Please confirm ASTRAZENECA PHARMA Standard Deviation, Information Ratio, Treynor Ratio, as well as the relationship between Variance and Jensen Alpha to decide if ASTRAZENECA PHARMA will be following its price patterns.
00

Risk-Adjusted Performance

Over the last 30 days ASTRAZENECA PHARMA INDIA LTD has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ASTRAZENECA PHARMA is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short term losses for the investors.

ASTRAZENECA PHARMA Relative Risk vs. Return Landscape

If you would invest (100.00)  in ASTRAZENECA PHARMA INDIA LTD on January 18, 2020 and sell it today you would earn a total of  100.00  from holding ASTRAZENECA PHARMA INDIA LTD or generate -100.0% return on investment over 30 days. ASTRAZENECA PHARMA INDIA LTD is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than ASTRAZENECA PHARMA and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
    
  Risk (%) 

ASTRAZENECA PHARMA Market Risk Analysis

Sharpe Ratio = 0.0
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
506820
Based on monthly moving average ASTRAZENECA PHARMA is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ASTRAZENECA PHARMA by adding it to a well-diversified portfolio.

ASTRAZENECA PHARMA Alerts

Equity Alerts and Improvement Suggestions

ASTRAZENECA PHARMA is not yet fully synchronised with the market data
ASTRAZENECA PHARMA has some characteristics of a very speculative penny stock
Check out Trending Equities. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Company logos by clearbit